Disclaimer and Safe Harbor


Statements made about AxoProtego, other than statements of historical fact, reflect Management’s current beliefs and assumptions founded on the data and information currently available to us. Statements of the company’s progress, results, timing of pre-clinical and clinical trials and projections for product pipelines are examples of forward-looking statements. By definition, such undertakings involve risks, uncertainties and assumptions, and are subject to a number of such factors that could cause actual results to differ substantially from statements made, including but not limited to: risks associated with the success of clinical trials; research and development programs; regulatory approval processes for clinical trials; competitive technologies and products; patents, inception and/or continuation of corporate and other strategic partnerships and the need for additional funding or financing.

The information contained in this presentation does not purport to be all-inclusive or to contain all of the information that prospective investors may desire. In all cases, interested parties should conduct their own investigation and analysis of AxoProtego’s business. No representation or warranty is made as to the accuracy or completeness of these materials, and the only representations or warranties that will be made in connection with any further investment will be the representations and warranties, as may be set forth in the definitive documentation executed by a duly authorized representative of AxoProtego.